Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Sadasivan, Shankar ^a   Zanin, Mark ^a   O'Brien, Kevin ^a   Schultz Cherry, Stacey ^a   Smeyne, Richard J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1; ARG1 PROTEIN, MOUSE; ARGINASE; CHEMOKINE; CSF1R PROTEIN, MOUSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARG1 GENE; ARTICLE; AVIAN INFLUENZA HPAI A VIETNAM 1203 2004 H5N1 VIRUS; BDNF GENE; BRAIN TISSUE; CCL4 GENE; CELL ACTIVATION; CELL ACTIVITY; CONTROLLED STUDY; CSF1 GENE; ENCEPHALITIS; FEMALE; GDNF GENE; GENE EXPRESSION; GLIOSIS; HIPPOCAMPUS; INFLUENZA; INFLUENZA VIRUS; MICROGLIA; MOUSE; NEUROTROPISM; NON NEUROTROPIC INFLUENZA VIRUS A CALIFORNIA 04 2009 H1N1; NONHUMAN; PARKINSONISM; POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; TGFBETA1 GENE; VIRUS GENE; ANIMAL; BLOOD BRAIN BARRIER; C57BL MOUSE; CLASSIFICATION; DENTATE GYRUS; GENETICS; INFLUENZA A VIRUS (H1N1); METABOLISM; ORTHOMYXOVIRIDAE INFECTIONS; PATHOGENICITY; PATHOLOGY; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA PARS COMPACTA; T LYMPHOCYTE; VIROLOGY;

AVES; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; ARGINASE; BLOOD-BRAIN BARRIER; CHEMOKINES; DENTATE GYRUS; ENCEPHALITIS; FEMALE; GENE EXPRESSION; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED C57BL; MICROGLIA; NERVE GROWTH FACTORS; ORTHOMYXOVIRIDAE INFECTIONS; PARS COMPACTA; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84929458465     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124047     Document Type: Article

References (66)

1. Yoon SW, Webby RJ, Webster RG. Evolution and Ecology of Influenza A Viruses. Curr Top Microbiol Immunol. 2014; 385: 359-375. doi: 10.1007/82-2014-396 PMID: 24990620
2. Fuchigami T, Imai Y, Hasegawa M, Ishii W, Endo A, Arakawa C, et al. Acute encephalopathy with pandemic (H1N1) 2009 virus infection. Pediatr Emerg Care. 2012; 28: 998-1002. doi: 10.1097/PEC.0b013e31826ca999 PMID: 23023467
3. Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003; 28: 225-232. PMID: 14522059
4. Ekstrand JJ. Neurologic complications of influenza. Semin Pediatr Neurol. 2012; 19: 96-100. doi: 10.1016/j.spen.2012.02.004 PMID: 22889537
5. Maeda K, Idehara R. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccination. Intern Med. 2012; 51: 1931-1933. PMID: 22821116
6. Henry J, Smeyne RJ, Jang H, Miller B, Okun MS. Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries. Parkinsonism Relat Disord. 2010.
7. Frisullo G, Iorio R, Plantone D, Nociti V, Patanella AK, Marti A, et al. Involvement of type I immune responses in swine-origin H1N1 influenza virus infection. Hum Immunol. 2011; 72: 632-635. doi: 10.1016/j.humimm.2011.04.006 PMID: 21571020
8. Mukherjee A, Peterson JE, Sandberg G, Takei H, Adesina A, Goodman JC, et al. Central nervous system pathology in fatal swine-origin influenza A H1N1 virus infection in patients with and without neurological symptoms: an autopsy study of 15 cases. Acta Neuropathol. 2011; 122: 371-373. doi: 10.1007/s00401-011-0854-7 PMID: 21744080
9. Jang H, Boltz D, McClaren J, Pani AK, Smeyne M, Korff A, et al. Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. J Neurosci. 2012; 32: 1545-1559. doi: 10.1523/JNEUROSCI.5123-11.2012 PMID: 22302798
10. Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y, Webster R, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A. 2009; 106: 14063-14068. doi: 10.1073/pnas.0900096106 PMID: 19667183
11. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005; 308: 1314-1318. PMID: 15831717
12. Xue QS, Yang C, Hoffman PM, Streit WJ. Microglial response to murine leukemia virus-induced encephalopathy is a good indicator of neuronal perturbations. Brain Res. 2010; 1319: 131-141. doi: 10.1016/j.brainres.2009.12.089 PMID: 20059990
13. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 1988; 334: 260-262. PMID: 3041283
14. Abutbul S, Shapiro J, Szaingurten-Solodkin I, Levy N, Carmy Y, Baron R, et al. TGF-beta signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment. Glia. 2012; 60: 1160-1171. doi: 10.1002/glia.22343 PMID: 22511296
15. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol. 1993; 151: 2150-2158. PMID: 8345199
16. Pizza V, Agresta A, D'Acunto CW, Festa M, Capasso A. Neuroinflamm-aging and neurodegenerative diseases: an overview. CNS Neurol Disord Drug Targets. 2011; 10: 621-634. PMID: 21631404
17. Ramesh G, MacLean AG, Philipp MT. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013; 2013: 480739. doi: 10.1155/2013/480739 PMID: 23997430
18. Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y, Webster R, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A. 2009; 106: 14063-14068. doi: 10.1073/pnas.0900096106 PMID: 19667183
19. Jurgens HA, Amancherla K, Johnson RW. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci. 2012; 32: 3958-3968. doi: 10.1523/JNEUROSCI.6389-11.2012 PMID: 22442063
20. Duchamp MB, Casalegno JS, Gillet Y, Frobert E, Bernard E, Escuret V, et al. Pandemic A(H1N1)2009 influenza virus detection by real time RT-PCR: is viral quantification useful? Clin Microbiol Infect. 2010; 16: 317-321. doi: 10.1111/j.1469-0691.2010.03169.x PMID: 20121827
21. Muhammad Ismail HI, Teh CM, Lee YL, on behalf of National Paediatric HNSG. Neurologic manifestations and complications of pandemic influenza A H1N1 in Malaysian children: What have we learnt from the ordeal? Brain Dev. 2014.
22. Phares TW, Kean RB, Mikheeva T, Hooper DC. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol. 2006; 176: 7666-7675. PMID: 16751414
23. Nishioku T, Dohgu S, Takata F, Eto T, Ishikawa N, Kodama KB, et al. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell Mol Neurobiol. 2009; 29: 309-316. doi: 10.1007/s10571-008-9322-x PMID: 18987969
24. Myint KS, Kipar A, Jarman RG, Gibbons RV, Perng GC, Flanagan B, et al. Neuropathogenesis of Japanese encephalitis in a primate model. PLoS Negl Trop Dis. 2014; 8: e2980. doi: 10.1371/journal.pntd.0002980 PMID: 25102067
25. Lyck R, Engelhardt B. Going against the tide-how encephalitogenic T cells breach the blood-brain barrier. J Vasc Res. 2012; 49: 497-509. doi: 10.1159/000341232 PMID: 22948545
26. Makwana M, Jones LL, Cuthill D, Heuer H, Bohatschek M, Hristova M, et al. Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS. J Neurosci. 2007; 27: 11201-11213. PMID: 17942715
27. Martinez-Canabal A. Potential neuroprotective role of transforming growth factor beta1 (TGFbeta1) in the brain. Int J Neurosci. 2014.
28. Colton C, Wilcock DM. Assessing activation states in microglia. CNS Neurol Disord Drug Targets. 2010; 9: 174-191. PMID: 20205642
29. Luo J, Elwood F, Britschgi M, Villeda S, Zhang H, Ding Z, et al. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J Exp Med. 2013; 210: 157-172. doi: 10.1084/jem.20120412 PMID: 23296467
30. Cuadros MA, Navascues J. The origin and differentiation of microglial cells during development. Prog Neurobiol. 1998; 56: 173-189. PMID: 9760700
31. Graeber MB, Streit WJ. Microglia: biology and pathology. Acta Neuropathol. 2010; 119: 89-105. doi: 10.1007/s00401-009-0622-0 PMID: 20012873
32. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 2009; 4: 399-418. doi: 10.1007/s11481-009-9164-4 PMID: 19655259
33. Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010; 37: 510-518. doi: 10.1016/j.nbd.2009.11.004 PMID: 19913097
34. Mitchell K, Shah JP, Tsytsikova LV, Campbell AM, Affram K, Symes AJ. LPS antagonism of TGF-beta signaling results in prolonged survival and activation of rat primary microglia. J Neurochem. 2014; 129: 155-168. doi: 10.1111/jnc.12612 PMID: 24251648
35. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol. 2004; 76: 509-513. PMID: 15218057
36. Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther. 2004; 9: 682-688. PMID: 15120329
37. Nakajima K, Hida H, Shimano Y, Fujimoto I, Hashitani T, Kumazaki M, et al. GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res. 2001; 916: 76-84. PMID: 11597593
38. Neumann H, Misgeld T, Matsumuro K, Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci U S A. 1998; 95: 5779-5784. PMID: 9576961
39. Moehle MS, West AB. M1 and M2 immune activation in Parkinson's Disease: Foe and ally? Neuroscience. 2014.
40. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009; 27: 451-483. doi: 10.1146/annurev.immunol.021908.132532 PMID: 19105661
41. Kiefer R, Gold R, Gehrmann J, Lindholm D, Wekerle H, Kreutzberg GW. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. J Neurosci Res. 1993; 36: 391-398. PMID: 7505838
42. Klempt ND, Sirimanne E, Gunn AJ, Klempt M, Singh K, Williams C, et al. Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain. Brain Res Mol Brain Res. 1992; 13: 93-101. PMID: 1315921
43. Logan A, Berry M, Gonzalez AM, Frautschy SA, Sporn MB, Baird A. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci. 1994; 6: 355-363. PMID: 8019673
44. Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia. 2007; 55: 412-424. PMID: 17203473
45. Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, et al. Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab. 2013; 33: 13-21. doi: 10.1038/jcbfm.2012.153 PMID: 23072749
46. Mizoguchi Y, Kato TA, Seki Y, Ohgidani M, Sagata N, Horikawa H, et al. Brain-derived Neurotrophic Factor (BDNF) Induces Sustained Intracellular Ca2+ Elevation through the Up-regulation of Surface Transient Receptor Potential 3 (TRPC3) Channels in Rodent Microglia. J Biol Chem. 2014; 289: 18549-18555. doi: 10.1074/jbc.M114.555334 PMID: 24811179
47. Chen XX, Quan R, Guo XK, Gao L, Shi J, Feng WH. Up-regulation of pro-inflammatory factors by HP-PRRSV infection in microglia: implications for HP-PRRSV neuropathogenesis. Vet Microbiol. 2014; 170: 48-57. doi: 10.1016/j.vetmic.2014.01.031 PMID: 24581811
48. Louboutin JP, Strayer DS. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy. CNS Neurol Disord Drug Targets. 2013; 12: 815-829. PMID: 24047524
49. Alon R, Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol. 2008; 20: 525-532. doi: 10.1016/j.ceb.2008.04.003 PMID: 18499427
50. Grabovsky V, Feigelson S, Chen C, Bleijs DA, Peled A, Cinamon G, et al. Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med. 2000; 192: 495-506. PMID: 10952719
51. Manes TD, Pober JS. Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cells. J Immunol. 2008; 180: 8386-8392. PMID: 18523306
52. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992; 68: 869-877. PMID: 1547488
53. Aldridge JR Jr., Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A. 2009; 106: 5306-5311. doi: 10.1073/pnas.0900655106 PMID: 19279209
54. Thomas PG, Brown SA, Morris MY, Yue W, So J, Reynolds C, et al. Physiological numbers of CD4+ T cells generate weak recall responses following influenza virus challenge. J Immunol. 2010; 184: 1721-1727. doi: 10.4049/jimmunol.0901427 PMID: 20061406
55. Thomas PG, Brown SA, Yue W, So J, Webby RJ, Doherty PC. An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses. Proc Natl Acad Sci U S A. 2006; 103: 2764-2769. PMID: 16473934
56. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007; 8: 57-69. PMID: 17180163
57. Hayakawa K, Okazaki R, Morioka K, Nakamura K, Tanaka S, Ogata T. Lipopolysaccharide preconditioning facilitates M2 activation of resident microglia after spinal cord injury. J Neurosci Res. 2014.
58. Madore C, Joffre C, Delpech JC, De Smedt-Peyrusse V, Aubert A, Coste L, et al. Early morphofunctional plasticity of microglia in response to acute lipopolysaccharide. Brain Behav Immun. 2013; 34: 151-158. doi: 10.1016/j.bbi.2013.08.008 PMID: 23994463
59. Taylor RA, Sansing LH. Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol. 2013; 2013: 746068. doi: 10.1155/2013/746068 PMID: 24223607
60. Reed LJ, Muench H. A simple method of estimating 50 per cent end-points. Amer J Hygiene. 1938: 493-497.
61. Matsuoka Y, Lamirande EW, Subbarao K. The mouse model for influenza. Curr Protoc Microbiol. 2009; Chapter 15: Unit 15G 13.
62. Baquet ZC, Williams D, Brody J, Smeyne RJ. A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J Mouse. Neuroscience. 2009; 161: 1082-1090. doi: 10.1016/j.neuroscience.2009.04. 031 PMID: 19376196
63. Sadasivan S, Pond BB, Pani AK, Qu C, Jiao Y, Smeyne RJ. Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice. PLoS One. 2012; 7: e33693. doi: 10.1371/journal.pone.0033693 PMID: 22470460
64. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec. 1991; 231: 482-497. PMID: 1793176
65. Suidan GL, McDole JR, Chen Y, Pirko I, Johnson AJ. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One. 2008; 3: e3037. doi: 10.1371/journal.pone.0003037 PMID: 18725947
66. Gralinski LE, Ashley SL, Dixon SD, Spindler KR. Mouse adenovirus type 1-induced breakdown of the blood-brain barrier. J Virol. 2009; 83: 9398-9410. doi: 10.1128/JVI.00954-09 PMID: 19570856